Biosense Webster, Inc. recalls WaveCrest Left Atrial Appendage (LAA), Occlusion System (32 mm), Catalog Numbers WCR1523 and WCR2523.
- Recall date
- May 7, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2878-2018
- FDA classification
- Class I
- Brand / firm
- Biosense Webster, Inc.
- Sold / distributed
- No U.S. Distribution. International Distribution only.
Why it was recalled
When attempting to recapture the 32-mm device, the tip of the delivery sheath may fold or buckle, resulting in increased retraction force and difficulty or failure to recapture the device.
Class I is the FDA’s most serious recall level: there is a reasonable probability that using this product will cause serious harm or death.
What was recalled
WaveCrest Left Atrial Appendage (LAA), Occlusion System (32 mm), Catalog Numbers WCR1523 and WCR2523.
Get recall alerts
Free email alert whenever Biosense Webster, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Biosense Webster, Inc.